Valley Fever News Archive

Athletes show us that everyone is susceptible to Valley fever, caused by a fungus that lurks in the dirt of the U.S. Southwest. But they also show us that knowledge is power, and that early diagnosis can make a difference.

The Division of Infectious Diseases and Valley Fever Center for Excellence physician-scientist is on the front line in the fight for her patients and to bring increased attention to the fungal disease.

A human Valley fever vaccine candidate will proceed toward Phase 1 clinical trials thanks to a major investment from the National Institutes of Health.

John Galgiani, MD, director of the UArizona College of Medicine – Tucson’s Valley Fever Center for Excellence, was recognized for his expertise by the New England Journal of Medicine.

The infectious diseases professor and Valley Fever Center for Excellence director recognized for a nearly 50-year career.

For four decades, John Galgiani, MD, has pioneered translational research and clinical care for Valley fever, a disease more common in Arizona than anywhere else.

To increase the chances of receiving proper care, people with symptoms of pneumonia should ask to be tested for Valley fever.

The findings are being used to improve patient care by identifying the illness sooner, preventing infection spread and reducing treatment costs.

Expenses for the fungal disease endemic to the Southwest can skyrocket for people whose diagnosis is delayed, leading to more serious infection or death.